Unknown

Dataset Information

0

Association of QT-Prolonging Medications With Risk of Autopsy-Defined Causes of Sudden Death.


ABSTRACT:

Importance

QT-prolonging medications (QTPMs) are a reported risk factor for sudden cardiac death (SCD) when defined by consensus criteria that presume an arrhythmic cause. The effect of QTPM on autopsy-defined sudden arrhythmic death (SAD) is unknown.

Objective

To evaluate the association between QTPM and autopsy-defined SAD vs nonarrhythmic cause of sudden death.

Design, setting, and participants

This prospective countywide case-control study included World Health Organization-defined (presumed) SCD cases who underwent autopsy as part of the San Francisco Postmortem Systematic Investigation of Sudden Cardiac Death Study (POST SCD) to determine arrhythmic or nonarrhythmic cause, and control deaths due to trauma (hereinafter referred to as trauma controls) in San Francisco County, California, from February 1, 2011, to March 1, 2014. Multivariate regression was used to evaluate the association of QTPM with the risk of presumed SCD, autopsy-defined SAD, and non-SAD compared with trauma controls. Medication exposure, determined by prescription lists and postmortem toxicologic findings, was used to calculate a summative QTPM exposure score (range, 0-20). Data were analyzed from September 1, 2018, to June 15, 2019.

Exposure

QT-prolonging medication exposure, as measured by QTPM score (1 indicated low; 2-4, moderate; and >4, high).

Main outcomes and measures

Death due to trauma, presumed SCD, and autopsy-defined non-SAD and SAD with no postmortem findings of extracardiac cause.

Results

A total of 629 patients (mean [SD] age, 61.4 [15.7] years; 439 men [69.8%]) were included, 525 with presumed SCDs and 104 traumatic death controls. Individuals with presumed SCDs had higher exposure and were more likely to be taking any QTPM (291 [55.4%] vs 28 [26.9%]; P?Conclusions and relevanceThese findings confirm the association between QTPMs and presumed SCD; however, after autopsy, this risk was specific for nonarrhythmic causes of sudden death. Studies using consensus SCD criteria may overestimate the association of QTPMs with the risk of SAD.

SUBMITTER: Simpson TF 

PROVIDER: S-EPMC7052791 | biostudies-literature | 2020 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Association of QT-Prolonging Medications With Risk of Autopsy-Defined Causes of Sudden Death.

Simpson Timothy F TF   Salazar James W JW   Vittinghoff Eric E   Probert Joanne J   Iwahashi Alan A   Olgin Jeffrey E JE   Ursell Phillip P   Hart Amy A   Moffatt Ellen E   Tseng Zian H ZH  

JAMA internal medicine 20200501 5


<h4>Importance</h4>QT-prolonging medications (QTPMs) are a reported risk factor for sudden cardiac death (SCD) when defined by consensus criteria that presume an arrhythmic cause. The effect of QTPM on autopsy-defined sudden arrhythmic death (SAD) is unknown.<h4>Objective</h4>To evaluate the association between QTPM and autopsy-defined SAD vs nonarrhythmic cause of sudden death.<h4>Design, setting, and participants</h4>This prospective countywide case-control study included World Health Organiza  ...[more]

Similar Datasets

| S-EPMC4078670 | biostudies-literature
| S-EPMC10127135 | biostudies-literature
| S-EPMC5659833 | biostudies-literature
| S-EPMC7670513 | biostudies-literature
| S-EPMC4195652 | biostudies-literature
| S-EPMC5586585 | biostudies-literature
| S-EPMC8394514 | biostudies-literature
| S-EPMC8649505 | biostudies-literature
| S-EPMC10062343 | biostudies-literature
| S-EPMC8435112 | biostudies-literature